the hepatitis b virus is a major public health problem worldwide and is a major public health problem worldwide. the development of new therapies for coronaviruses is rapidly evolving and is now being challenged by the development of new therapies for corona viruses. we are now working on a new strategy to address this global health crisis and we are now working on new therapies for coronaviruses. we are now working on new molecules that target specific viral targets that fit well with our expertise. we are now working on a strategy to develop small molecule antivirals for coronaviruses and we will continue to continue our research efforts for a next- generation capsid inhibitor, a new new capsid inhibitor and a lead oral compound that inhibits PD-l1.